nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCC2—Carboplatin—bone cancer	0.181	0.233	CbGbCtD
Spironolactone—ABCC2—Cisplatin—bone cancer	0.154	0.199	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—bone cancer	0.121	0.156	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—bone cancer	0.103	0.133	CbGbCtD
Spironolactone—ABCC2—Methotrexate—bone cancer	0.1	0.129	CbGbCtD
Spironolactone—ABCB1—Cisplatin—bone cancer	0.0503	0.0648	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—bone cancer	0.0337	0.0434	CbGbCtD
Spironolactone—ABCB1—Methotrexate—bone cancer	0.0327	0.0421	CbGbCtD
Spironolactone—CYP11B2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00951	0.057	CbGpPWpGaD
Spironolactone—CYP11B1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00819	0.0491	CbGpPWpGaD
Spironolactone—ABCC2—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.0047	0.0282	CbGpPWpGaD
Spironolactone—NR3C2—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00454	0.0272	CbGpPWpGaD
Spironolactone—NR3C1—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.00453	0.0272	CbGpPWpGaD
Spironolactone—ABCC2—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.0044	0.0264	CbGpPWpGaD
Spironolactone—CYP11B2—Metapathway biotransformation—CYP4V2—bone cancer	0.00409	0.0245	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—T—bone cancer	0.00369	0.0221	CbGpPWpGaD
Spironolactone—CYP11B1—Metapathway biotransformation—CYP4V2—bone cancer	0.00353	0.0211	CbGpPWpGaD
Spironolactone—PGR—Nuclear Receptors—NR1I2—bone cancer	0.0035	0.021	CbGpPWpGaD
Spironolactone—ABCC2—Irinotecan Pathway—CYP3A4—bone cancer	0.003	0.018	CbGpPWpGaD
Spironolactone—PGR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00277	0.0166	CbGpPWpGaD
Spironolactone—AR—Nuclear Receptors—NR1I2—bone cancer	0.00267	0.016	CbGpPWpGaD
Spironolactone—ABCC2—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00257	0.0154	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—FEV—bone cancer	0.00255	0.0153	CbGpPWpGaD
Spironolactone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00253	0.0152	CbGpPWpGaD
Spironolactone—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00252	0.0151	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00241	0.0145	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—ZNF77—bone cancer	0.00232	0.0139	CbGpPWpGaD
Spironolactone—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00221	0.0132	CbGpPWpGaD
Spironolactone—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.00214	0.0128	CbGpPWpGaD
Spironolactone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—bone cancer	0.00211	0.0127	CbGpPWpGaD
Spironolactone—AR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.00211	0.0126	CbGpPWpGaD
Spironolactone—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00207	0.0124	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00206	0.0124	CbGpPWpGaD
Spironolactone—NR3C1—Nuclear Receptors—NR1I2—bone cancer	0.00202	0.0121	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00193	0.0116	CbGpPWpGaD
Spironolactone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.0019	0.0114	CbGpPWpGaD
Spironolactone—CYP11B2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00188	0.0113	CbGpPWpGaD
Spironolactone—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00164	0.00984	CbGpPWpGaD
Spironolactone—CYP11B1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00162	0.00971	CbGpPWpGaD
Spironolactone—NR3C1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.0016	0.00959	CbGpPWpGaD
Spironolactone—ABCC2—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00155	0.00929	CbGpPWpGaD
Spironolactone—CYP11B2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00154	0.00926	CbGpPWpGaD
Spironolactone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00148	0.00885	CbGpPWpGaD
Spironolactone—PGR—Ovarian Infertility Genes—CDK4—bone cancer	0.00145	0.00872	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—ZNF77—bone cancer	0.00141	0.00846	CbGpPWpGaD
Spironolactone—CYP11B1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00133	0.00798	CbGpPWpGaD
Spironolactone—Ulcer—Cisplatin—bone cancer	0.00132	0.0267	CcSEcCtD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—GNA11—bone cancer	0.00129	0.00771	CbGpPWpGaD
Spironolactone—Hydrocortamate—CYP3A4—bone cancer	0.00127	0.174	CrCbGaD
Spironolactone—Cortisone acetate—CYP3A4—bone cancer	0.00125	0.171	CrCbGaD
Spironolactone—Hyperkalaemia—Cisplatin—bone cancer	0.00123	0.0248	CcSEcCtD
Spironolactone—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.00122	0.0073	CbGpPWpGaD
Spironolactone—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00121	0.00725	CbGpPWpGaD
Spironolactone—Body temperature increased—Carboplatin—bone cancer	0.0012	0.0243	CcSEcCtD
Spironolactone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00119	0.00712	CbGpPWpGaD
Spironolactone—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.00117	0.00702	CbGpPWpGaD
Spironolactone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—bone cancer	0.00113	0.00677	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ZNF77—bone cancer	0.00112	0.00669	CbGpPWpGaD
Spironolactone—Eplerenone—CYP3A4—bone cancer	0.0011	0.15	CrCbGaD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.00109	0.00651	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ZNF77—bone cancer	0.00108	0.00645	CbGpPWpGaD
Spironolactone—Drospirenone—PTGS2—bone cancer	0.00103	0.141	CrCbGaD
Spironolactone—Renal failure acute—Cisplatin—bone cancer	0.00098	0.0199	CcSEcCtD
Spironolactone—Rash erythematous—Epirubicin—bone cancer	0.000836	0.0169	CcSEcCtD
Spironolactone—CYP11B2—Biological oxidations—CYP3A4—bone cancer	0.00082	0.00492	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ZNF77—bone cancer	0.000816	0.00489	CbGpPWpGaD
Spironolactone—Cramp muscle—Cisplatin—bone cancer	0.000815	0.0165	CcSEcCtD
Spironolactone—NR3C1—Endoderm Differentiation—EZH2—bone cancer	0.000815	0.00489	CbGpPWpGaD
Spironolactone—CYP11B2—Metapathway biotransformation—CYP3A4—bone cancer	0.000809	0.00485	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—NR1I2—bone cancer	0.000785	0.0047	CbGpPWpGaD
Spironolactone—Rash erythematous—Doxorubicin—bone cancer	0.000774	0.0157	CcSEcCtD
Spironolactone—Breast pain—Epirubicin—bone cancer	0.000734	0.0149	CcSEcCtD
Spironolactone—Amenorrhoea—Epirubicin—bone cancer	0.000729	0.0148	CcSEcCtD
Spironolactone—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000729	0.00437	CbGpPWpGaD
Spironolactone—Ulcer—Methotrexate—bone cancer	0.000723	0.0147	CcSEcCtD
Spironolactone—AR—Notch-mediated HES/HEY network—RB1—bone cancer	0.000709	0.00425	CbGpPWpGaD
Spironolactone—CYP11B1—Biological oxidations—CYP3A4—bone cancer	0.000707	0.00424	CbGpPWpGaD
Spironolactone—Medroxyprogesterone Acetate—CYP3A4—bone cancer	0.000702	0.0962	CrCbGaD
Spironolactone—CYP11B2—Biological oxidations—GSTP1—bone cancer	0.000702	0.00421	CbGpPWpGaD
Spironolactone—Vasculitis—Methotrexate—bone cancer	0.000701	0.0142	CcSEcCtD
Spironolactone—CYP11B1—Metapathway biotransformation—CYP3A4—bone cancer	0.000697	0.00418	CbGpPWpGaD
Spironolactone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000694	0.00416	CbGpPWpGaD
Spironolactone—CYP11B2—Metapathway biotransformation—GSTP1—bone cancer	0.000692	0.00415	CbGpPWpGaD
Spironolactone—Renal failure—Cisplatin—bone cancer	0.000686	0.0139	CcSEcCtD
Spironolactone—PGR—Gene Expression—ZNF77—bone cancer	0.00068	0.00408	CbGpPWpGaD
Spironolactone—Breast pain—Doxorubicin—bone cancer	0.000679	0.0138	CcSEcCtD
Spironolactone—Ulcer—Epirubicin—bone cancer	0.000677	0.0137	CcSEcCtD
Spironolactone—Amenorrhoea—Doxorubicin—bone cancer	0.000674	0.0137	CcSEcCtD
Spironolactone—Methyltestosterone—CYP3A4—bone cancer	0.000661	0.0906	CrCbGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—BRAF—bone cancer	0.00064	0.00384	CbGpPWpGaD
Spironolactone—Hyperkalaemia—Epirubicin—bone cancer	0.000629	0.0128	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—bone cancer	0.000626	0.0127	CcSEcCtD
Spironolactone—Gynaecomastia—Methotrexate—bone cancer	0.000612	0.0124	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000607	0.00364	CbGpPWpGaD
Spironolactone—CYP11B1—Biological oxidations—GSTP1—bone cancer	0.000605	0.00363	CbGpPWpGaD
Spironolactone—CYP11B1—Metapathway biotransformation—GSTP1—bone cancer	0.000596	0.00358	CbGpPWpGaD
Spironolactone—Cramps of lower extremities—Epirubicin—bone cancer	0.000588	0.0119	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—bone cancer	0.000582	0.0118	CcSEcCtD
Spironolactone—AR—FOXA1 transcription factor network—JUN—bone cancer	0.000554	0.00332	CbGpPWpGaD
Spironolactone—Alopecia—Cisplatin—bone cancer	0.000553	0.0112	CcSEcCtD
Spironolactone—AR—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000549	0.00329	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—FUS—bone cancer	0.000545	0.00327	CbGpPWpGaD
Spironolactone—Cramps of lower extremities—Doxorubicin—bone cancer	0.000544	0.011	CcSEcCtD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.000538	0.00323	CbGpPWpGaD
Spironolactone—Renal failure acute—Methotrexate—bone cancer	0.000538	0.0109	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.00053	0.00318	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000527	0.00316	CbGpPWpGaD
Spironolactone—Muscle spasms—Cisplatin—bone cancer	0.000524	0.0106	CcSEcCtD
Spironolactone—AR—Gene Expression—ZNF77—bone cancer	0.000518	0.0031	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000516	0.0031	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.00051	0.00306	CbGpPWpGaD
Spironolactone—Lethargy—Methotrexate—bone cancer	0.000507	0.0103	CcSEcCtD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000506	0.00303	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Cisplatin—bone cancer	0.000506	0.0103	CcSEcCtD
Spironolactone—Renal failure acute—Epirubicin—bone cancer	0.000503	0.0102	CcSEcCtD
Spironolactone—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000499	0.00299	CbGpPWpGaD
Spironolactone—Hydrocortisone—CYP3A4—bone cancer	0.000498	0.0682	CrCbGaD
Spironolactone—CYP11B2—Metabolism—NDUFA12—bone cancer	0.000492	0.00295	CbGpPWpGaD
Spironolactone—Malaise—Cisplatin—bone cancer	0.000492	0.00996	CcSEcCtD
Spironolactone—Leukopenia—Cisplatin—bone cancer	0.000488	0.00989	CcSEcCtD
Spironolactone—PGR—Generic Transcription Pathway—NR1I2—bone cancer	0.000478	0.00287	CbGpPWpGaD
Spironolactone—AR—Regulation of Androgen receptor activity—JUN—bone cancer	0.000477	0.00286	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—PLAU—bone cancer	0.000476	0.00285	CbGpPWpGaD
Spironolactone—Lethargy—Epirubicin—bone cancer	0.000474	0.00961	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00047	0.00282	CbGpPWpGaD
Spironolactone—Ataxia—Methotrexate—bone cancer	0.000467	0.00947	CcSEcCtD
Spironolactone—Renal failure acute—Doxorubicin—bone cancer	0.000466	0.00944	CcSEcCtD
Spironolactone—Discomfort—Cisplatin—bone cancer	0.000459	0.00929	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000447	0.00907	CcSEcCtD
Spironolactone—Anaphylactic shock—Cisplatin—bone cancer	0.000445	0.00902	CcSEcCtD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bone cancer	0.000444	0.00266	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000442	0.00265	CbGpPWpGaD
Spironolactone—Lethargy—Doxorubicin—bone cancer	0.000439	0.0089	CcSEcCtD
Spironolactone—Ataxia—Epirubicin—bone cancer	0.000437	0.00886	CcSEcCtD
Spironolactone—Thrombocytopenia—Cisplatin—bone cancer	0.000436	0.00883	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000432	0.00259	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000428	0.00257	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—RB1—bone cancer	0.000425	0.00255	CbGpPWpGaD
Spironolactone—Eosinophilia—Methotrexate—bone cancer	0.000425	0.00862	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—NDUFA12—bone cancer	0.000424	0.00254	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000422	0.00253	CbGpPWpGaD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000419	0.00848	CcSEcCtD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000416	0.0025	CbGpPWpGaD
Spironolactone—Gastritis—Epirubicin—bone cancer	0.000411	0.00834	CcSEcCtD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00041	0.00246	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NT5C3A—bone cancer	0.000407	0.00244	CbGpPWpGaD
Spironolactone—Progesterone—CYP3A4—bone cancer	0.000405	0.0556	CrCbGaD
Spironolactone—Ataxia—Doxorubicin—bone cancer	0.000404	0.0082	CcSEcCtD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.0004	0.0024	CbGpPWpGaD
Spironolactone—Eosinophilia—Epirubicin—bone cancer	0.000398	0.00806	CcSEcCtD
Spironolactone—Erectile dysfunction—Methotrexate—bone cancer	0.000395	0.00801	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—KIT—bone cancer	0.000394	0.00236	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—TGFBR2—bone cancer	0.000394	0.00236	CbGpPWpGaD
Spironolactone—ABCC2—NRF2 pathway—GSTP1—bone cancer	0.000394	0.00236	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ZNF77—bone cancer	0.000393	0.00236	CbGpPWpGaD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000387	0.00785	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Cisplatin—bone cancer	0.000384	0.00778	CcSEcCtD
Spironolactone—Testosterone—CYP3A4—bone cancer	0.000383	0.0525	CrCbGaD
Spironolactone—Drowsiness—Methotrexate—bone cancer	0.000383	0.00776	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—bone cancer	0.000381	0.00772	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000379	0.00769	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—NR1I2—bone cancer	0.000378	0.00226	CbGpPWpGaD
Spironolactone—Renal failure—Methotrexate—bone cancer	0.000376	0.00763	CcSEcCtD
Spironolactone—Eosinophilia—Doxorubicin—bone cancer	0.000368	0.00746	CcSEcCtD
Spironolactone—Feeling abnormal—Cisplatin—bone cancer	0.000367	0.00743	CcSEcCtD
Spironolactone—AR—Generic Transcription Pathway—NR1I2—bone cancer	0.000364	0.00218	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—MDM2—bone cancer	0.000362	0.00217	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—JUN—bone cancer	0.000362	0.00217	CbGpPWpGaD
Spironolactone—Drowsiness—Epirubicin—bone cancer	0.000358	0.00726	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000358	0.00215	CbGpPWpGaD
Spironolactone—Agranulocytosis—Methotrexate—bone cancer	0.000357	0.00724	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000355	0.0072	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—bone cancer	0.000352	0.00714	CcSEcCtD
Spironolactone—Body temperature increased—Cisplatin—bone cancer	0.000352	0.00713	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—NT5C3A—bone cancer	0.000351	0.00211	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—bone cancer	0.000343	0.00206	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00034	0.00204	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.00034	0.00204	CbGpPWpGaD
Spironolactone—Agranulocytosis—Epirubicin—bone cancer	0.000334	0.00678	CcSEcCtD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bone cancer	0.000334	0.002	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—FUS—bone cancer	0.000332	0.00199	CbGpPWpGaD
Spironolactone—Drowsiness—Doxorubicin—bone cancer	0.000331	0.00672	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000329	0.00666	CcSEcCtD
Spironolactone—Hypersensitivity—Cisplatin—bone cancer	0.000328	0.00664	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—bone cancer	0.000326	0.0066	CcSEcCtD
Spironolactone—Erythema multiforme—Methotrexate—bone cancer	0.000325	0.00659	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.00032	0.00192	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—JUN—bone cancer	0.000315	0.00189	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—MDM2—bone cancer	0.00031	0.00186	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000309	0.00186	CbGpPWpGaD
Spironolactone—Agranulocytosis—Doxorubicin—bone cancer	0.000309	0.00627	CcSEcCtD
Spironolactone—Diarrhoea—Cisplatin—bone cancer	0.000304	0.00617	CcSEcCtD
Spironolactone—Erythema multiforme—Epirubicin—bone cancer	0.000304	0.00616	CcSEcCtD
Spironolactone—Alopecia—Methotrexate—bone cancer	0.000304	0.00615	CcSEcCtD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000302	0.00181	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—bone cancer	0.000294	0.00176	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000293	0.00176	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—JUN—bone cancer	0.00029	0.00174	CbGpPWpGaD
Spironolactone—Alopecia—Epirubicin—bone cancer	0.000284	0.00576	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000283	0.0017	CbGpPWpGaD
Spironolactone—Vomiting—Cisplatin—bone cancer	0.000283	0.00573	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—MMP9—bone cancer	0.000282	0.00169	CbGpPWpGaD
Spironolactone—Erythema multiforme—Doxorubicin—bone cancer	0.000281	0.0057	CcSEcCtD
Spironolactone—Rash—Cisplatin—bone cancer	0.000281	0.00569	CcSEcCtD
Spironolactone—Dermatitis—Cisplatin—bone cancer	0.00028	0.00568	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—EIF2S1—bone cancer	0.000279	0.00167	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000279	0.00167	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Methotrexate—bone cancer	0.000278	0.00563	CcSEcCtD
Spironolactone—NR3C1—Generic Transcription Pathway—NR1I2—bone cancer	0.000276	0.00166	CbGpPWpGaD
Spironolactone—Malaise—Methotrexate—bone cancer	0.00027	0.00547	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—bone cancer	0.000269	0.00546	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—bone cancer	0.000268	0.00543	CcSEcCtD
Spironolactone—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000267	0.0016	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NDUFA12—bone cancer	0.000266	0.00159	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000265	0.00159	CbGpPWpGaD
Spironolactone—Nausea—Cisplatin—bone cancer	0.000264	0.00536	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—bone cancer	0.000263	0.00533	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—bone cancer	0.00026	0.00526	CcSEcCtD
Spironolactone—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.000259	0.00155	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000258	0.00155	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—JUN—bone cancer	0.000255	0.00153	CbGpPWpGaD
Spironolactone—AR—Gene Expression—FUS—bone cancer	0.000253	0.00152	CbGpPWpGaD
Spironolactone—Malaise—Epirubicin—bone cancer	0.000252	0.00512	CcSEcCtD
Spironolactone—Discomfort—Methotrexate—bone cancer	0.000252	0.0051	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—bone cancer	0.000251	0.00508	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—bone cancer	0.000249	0.00505	CcSEcCtD
Spironolactone—AR—Androgen receptor signaling pathway—EGFR—bone cancer	0.000248	0.00149	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000247	0.00148	CbGpPWpGaD
Spironolactone—Confusional state—Methotrexate—bone cancer	0.000246	0.00499	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—bone cancer	0.000244	0.00495	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—EZH2—bone cancer	0.000242	0.00145	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Doxorubicin—bone cancer	0.00024	0.00487	CcSEcCtD
Spironolactone—Thrombocytopenia—Methotrexate—bone cancer	0.000239	0.00484	CcSEcCtD
Spironolactone—NR3C1—Adipogenesis—RB1—bone cancer	0.000238	0.00143	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000237	0.00142	CbGpPWpGaD
Spironolactone—Discomfort—Epirubicin—bone cancer	0.000235	0.00477	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—bone cancer	0.000234	0.00473	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—bone cancer	0.000232	0.0047	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—bone cancer	0.00023	0.00467	CcSEcCtD
Spironolactone—PGR—Gene Expression—NR1I2—bone cancer	0.00023	0.00138	CbGpPWpGaD
Spironolactone—Anaphylactic shock—Epirubicin—bone cancer	0.000228	0.00463	CcSEcCtD
Spironolactone—Thrombocytopenia—Epirubicin—bone cancer	0.000224	0.00453	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—NT5C3A—bone cancer	0.00022	0.00132	CbGpPWpGaD
Spironolactone—Discomfort—Doxorubicin—bone cancer	0.000218	0.00442	CcSEcCtD
Spironolactone—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000218	0.00131	CbGpPWpGaD
Spironolactone—Somnolence—Methotrexate—bone cancer	0.000217	0.0044	CcSEcCtD
Spironolactone—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000215	0.00129	CbGpPWpGaD
Spironolactone—Confusional state—Doxorubicin—bone cancer	0.000213	0.00432	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—EGFR—bone cancer	0.000212	0.00127	CbGpPWpGaD
Spironolactone—Anaphylactic shock—Doxorubicin—bone cancer	0.000211	0.00428	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Methotrexate—bone cancer	0.000211	0.00427	CcSEcCtD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00021	0.00126	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Doxorubicin—bone cancer	0.000207	0.0042	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000206	0.00124	CbGpPWpGaD
Spironolactone—Somnolence—Epirubicin—bone cancer	0.000203	0.00412	CcSEcCtD
Spironolactone—Feeling abnormal—Methotrexate—bone cancer	0.000201	0.00408	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—JUN—bone cancer	0.000201	0.00121	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000197	0.004	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000197	0.00118	CbGpPWpGaD
Spironolactone—Urticaria—Methotrexate—bone cancer	0.000194	0.00393	CcSEcCtD
Spironolactone—Body temperature increased—Methotrexate—bone cancer	0.000193	0.00391	CcSEcCtD
Spironolactone—NR3C1—Gene Expression—FUS—bone cancer	0.000192	0.00115	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000192	0.00115	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—bone cancer	0.000191	0.00115	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.00019	0.00114	CbGpPWpGaD
Spironolactone—Feeling abnormal—Epirubicin—bone cancer	0.000188	0.00382	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—bone cancer	0.000188	0.00381	CcSEcCtD
Spironolactone—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000186	0.00112	CbGpPWpGaD
Spironolactone—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000184	0.0011	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000183	0.0037	CcSEcCtD
Spironolactone—Urticaria—Epirubicin—bone cancer	0.000181	0.00368	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—bone cancer	0.000181	0.00366	CcSEcCtD
Spironolactone—Hypersensitivity—Methotrexate—bone cancer	0.00018	0.00365	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—ENO2—bone cancer	0.000178	0.00107	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NR1I2—bone cancer	0.000175	0.00105	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000174	0.00105	CbGpPWpGaD
Spironolactone—Feeling abnormal—Doxorubicin—bone cancer	0.000174	0.00353	CcSEcCtD
Spironolactone—Pruritus—Methotrexate—bone cancer	0.000173	0.0035	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—GRM4—bone cancer	0.000173	0.00103	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RGS1—bone cancer	0.000173	0.00103	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000172	0.00103	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000171	0.00103	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—EIF2S1—bone cancer	0.00017	0.00102	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—bone cancer	0.000168	0.00101	CbGpPWpGaD
Spironolactone—Hypersensitivity—Epirubicin—bone cancer	0.000168	0.00341	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—bone cancer	0.000168	0.0034	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—bone cancer	0.000167	0.00339	CcSEcCtD
Spironolactone—Diarrhoea—Methotrexate—bone cancer	0.000167	0.00339	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—DHFR—bone cancer	0.000166	0.000993	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000163	0.000978	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000162	0.000973	CbGpPWpGaD
Spironolactone—Pruritus—Epirubicin—bone cancer	0.000162	0.00328	CcSEcCtD
Spironolactone—Dizziness—Methotrexate—bone cancer	0.000161	0.00327	CcSEcCtD
Spironolactone—Diarrhoea—Epirubicin—bone cancer	0.000156	0.00317	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—bone cancer	0.000156	0.00316	CcSEcCtD
Spironolactone—Vomiting—Methotrexate—bone cancer	0.000155	0.00315	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—GNA11—bone cancer	0.000155	0.000928	CbGpPWpGaD
Spironolactone—Rash—Methotrexate—bone cancer	0.000154	0.00312	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—ENO2—bone cancer	0.000154	0.000922	CbGpPWpGaD
Spironolactone—Dermatitis—Methotrexate—bone cancer	0.000154	0.00312	CcSEcCtD
Spironolactone—Headache—Methotrexate—bone cancer	0.000153	0.0031	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—JUN—bone cancer	0.000153	0.000915	CbGpPWpGaD
Spironolactone—Dizziness—Epirubicin—bone cancer	0.000151	0.00306	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—GRM1—bone cancer	0.00015	0.000897	CbGpPWpGaD
Spironolactone—Pruritus—Doxorubicin—bone cancer	0.00015	0.00303	CcSEcCtD
Spironolactone—PGR—Gene Expression—EZH2—bone cancer	0.000148	0.000885	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000146	0.000875	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000145	0.000872	CbGpPWpGaD
Spironolactone—Vomiting—Epirubicin—bone cancer	0.000145	0.00294	CcSEcCtD
Spironolactone—Nausea—Methotrexate—bone cancer	0.000145	0.00294	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—bone cancer	0.000145	0.00293	CcSEcCtD
Spironolactone—Rash—Epirubicin—bone cancer	0.000144	0.00292	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—bone cancer	0.000144	0.00292	CcSEcCtD
Spironolactone—Headache—Epirubicin—bone cancer	0.000143	0.0029	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—DHFR—bone cancer	0.000143	0.000856	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CYP3A4—bone cancer	0.00014	0.000841	CbGpPWpGaD
Spironolactone—Dizziness—Doxorubicin—bone cancer	0.00014	0.00283	CcSEcCtD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.00014	0.000837	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000136	0.000817	CbGpPWpGaD
Spironolactone—Nausea—Epirubicin—bone cancer	0.000136	0.00275	CcSEcCtD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000134	0.000806	CbGpPWpGaD
Spironolactone—Vomiting—Doxorubicin—bone cancer	0.000134	0.00272	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—GNA11—bone cancer	0.000133	0.0008	CbGpPWpGaD
Spironolactone—Rash—Doxorubicin—bone cancer	0.000133	0.0027	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—bone cancer	0.000133	0.0027	CcSEcCtD
Spironolactone—NR3C1—Gene Expression—NR1I2—bone cancer	0.000133	0.000797	CbGpPWpGaD
Spironolactone—Headache—Doxorubicin—bone cancer	0.000132	0.00268	CcSEcCtD
Spironolactone—CYP2C8—Metabolism—NDUFA12—bone cancer	0.000131	0.000783	CbGpPWpGaD
Spironolactone—AR—Gene Expression—EIF2S1—bone cancer	0.000129	0.000776	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000126	0.000753	CbGpPWpGaD
Spironolactone—Nausea—Doxorubicin—bone cancer	0.000126	0.00255	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—CYP3A4—bone cancer	0.000121	0.000725	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.00012	0.000721	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—GSTP1—bone cancer	0.00012	0.000719	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NDUFA12—bone cancer	0.000114	0.000682	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000113	0.000677	CbGpPWpGaD
Spironolactone—AR—Gene Expression—EZH2—bone cancer	0.000112	0.000674	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000108	0.000649	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NT5C3A—bone cancer	0.000108	0.000649	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SMO—bone cancer	0.000105	0.000632	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—GSTP1—bone cancer	0.000103	0.00062	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—EIF2S1—bone cancer	9.82e-05	0.000589	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ENO2—bone cancer	9.64e-05	0.000578	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GNA11—bone cancer	9.64e-05	0.000578	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NT5C3A—bone cancer	9.42e-05	0.000565	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ATF1—bone cancer	8.96e-05	0.000537	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—DHFR—bone cancer	8.95e-05	0.000536	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL3—bone cancer	8.74e-05	0.000524	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—EZH2—bone cancer	8.53e-05	0.000512	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GNA11—bone cancer	8.36e-05	0.000501	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	8.02e-05	0.000481	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	7.73e-05	0.000464	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP3A4—bone cancer	7.58e-05	0.000455	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.54e-05	0.000452	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFBR2—bone cancer	7.47e-05	0.000448	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1R—bone cancer	7.03e-05	0.000422	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	6.97e-05	0.000418	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTP1—bone cancer	6.48e-05	0.000389	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—bone cancer	6.22e-05	0.000373	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	5.48e-05	0.000329	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—bone cancer	5.36e-05	0.000321	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KIT—bone cancer	5.1e-05	0.000306	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BRAF—bone cancer	4.79e-05	0.000287	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO2—bone cancer	4.74e-05	0.000284	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	4.6e-05	0.000276	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—DHFR—bone cancer	4.4e-05	0.000264	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO2—bone cancer	4.13e-05	0.000248	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNA11—bone cancer	4.11e-05	0.000246	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MDM2—bone cancer	4.02e-05	0.000241	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—DHFR—bone cancer	3.83e-05	0.00023	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP3A4—bone cancer	3.72e-05	0.000223	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	3.71e-05	0.000222	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNA11—bone cancer	3.58e-05	0.000215	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JUN—bone cancer	3.49e-05	0.000209	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—bone cancer	3.4e-05	0.000204	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—bone cancer	3.36e-05	0.000201	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP3A4—bone cancer	3.25e-05	0.000195	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTP1—bone cancer	3.19e-05	0.000191	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTP1—bone cancer	2.78e-05	0.000166	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—bone cancer	2.74e-05	0.000165	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—bone cancer	2.3e-05	0.000138	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—bone cancer	1.65e-05	9.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—bone cancer	1.44e-05	8.62e-05	CbGpPWpGaD
